American Journal of Hematology | 2025
Five-year real-world safety of Inotuzumab Ozogamicin before hematopoietic stem cell transplantation in B-cell precursor acute lymphoblastic leukemia.
de Lima M, Kebriaei P, Lanza F, Cho C, Popradi G, Kaur M, Zhang MJ, Zhang F, Shah R, Vandendries E, Asomaning K, Dorman S, Stelljes M, Marks DI, Saber W
PubMed
PMID: 39989181
Abstract
Related Articles
CIBMTR Study #: SC17-10